SubsidieMeestersThe InDx CMC Implant. A new treatment for thumb base joint arthritis.
The InDx CMC Implant offers a patented, evidence-based solution for thumb base joint arthritis, aiming to restore joint mobility and eliminate pain for an underserved aging population.
Projectdetails
Introduction
The InDx CMC Implant is for the treatment of thumb base joint arthritis. It is the first evidence-based, surgeon-led innovation, implant solution for this major clinical problem. The potential market is estimated at over €700M per year.
Clinical Need
The implant meets a major unmet clinical need for an ageing EU population.
Technology and Benefits
The implant re-creates the natural joint biomechanics to give a more reliable and clinically superior outcome for patients. This disruptive technology can change the treatment landscape for this condition. The implant provides an exciting new treatment option for an under-served population. It has been shown to eliminate pain and restore full joint mobility.
Advantages
The InDx Implant is smarter, safer, and simpler to insert than any current treatment options.
Regulatory Status
The InDx Implant is patented, with a clear pathway to regulatory clearance in the EU and US.
Team
The company is led by a physician-innovator and is supported by medical device industry veterans and world-leading hand surgeons.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 3.658.337 |
Tijdlijn
| Startdatum | 1-11-2022 |
| Einddatum | 30-4-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- LOCI ORTHOPAEDICS LIMITEDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from painNC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments. | EIC Accelerator | € 2.499.999 | 2023 | Details |
First in class lateral meniscus prothesis to relieve pain and restore mobility for KOA patientsATRO Medical's Trammpolin is a minimally invasive knee prosthesis designed to relieve pain and restore mobility in severe KOA patients, aiming for market entry in 2026 with a focus on health economics for reimbursement. | EIC Accelerator | € 2.499.402 | 2023 | Details |
The first true minimally-invasive Spinal Fusion SystemZygoFix's zLOCK implant aims to revolutionize spinal fusion by offering a minimally invasive, outpatient alternative to traditional screw-and-rod methods, with plans for clinical validation and CE-marking. | EIC Accelerator | € 2.220.050 | 2022 | Details |
A breakthrough active immunotherapy for the treatment of osteoarthritisPeptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from pain
NC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments.
First in class lateral meniscus prothesis to relieve pain and restore mobility for KOA patients
ATRO Medical's Trammpolin is a minimally invasive knee prosthesis designed to relieve pain and restore mobility in severe KOA patients, aiming for market entry in 2026 with a focus on health economics for reimbursement.
The first true minimally-invasive Spinal Fusion System
ZygoFix's zLOCK implant aims to revolutionize spinal fusion by offering a minimally invasive, outpatient alternative to traditional screw-and-rod methods, with plans for clinical validation and CE-marking.
A breakthrough active immunotherapy for the treatment of osteoarthritis
Peptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Development of an instrumented hammer to assess the stability of hip implant during surgery: assessment of the commercial feasibilityImpactor aims to develop a decision support system for assessing hip implant stability using an instrumented orthopedic hammer, enhancing surgical strategies and commercial potential in orthopedic surgery. | ERC Proof of... | € 150.000 | 2022 | Details |
IPDIPD en LUMC testen een innovatief handheld device voor het bestrijden van infecties in implantaten tijdens de FiH-studie. | 1.1 - Het ve... | € 18.750 | 2024 | Details |
SyCap MechanoAvalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten. | Mkb-innovati... | € 20.000 | 2022 | Details |
Implant Preservation DeviceHet project ontwikkelt een handheld inductie-apparaat om infecties bij metalen implantaten te bestrijden, wat de chirurgische behandeling vereenvoudigt en gezondheidszorgkosten verlaagt. | Mkb-innovati... | € 289.205 | 2021 | Details |
Precisie katheter ontwikkeling met Skeleton Backbone TechnologieHet project ontwikkelt innovatieve medische hulpmiddelen om patiëntgerichte zorg te verbeteren en productie in Nederland te versterken. | 1.1 - Onderz... | € 325.000 | 2024 | Details |
Development of an instrumented hammer to assess the stability of hip implant during surgery: assessment of the commercial feasibility
Impactor aims to develop a decision support system for assessing hip implant stability using an instrumented orthopedic hammer, enhancing surgical strategies and commercial potential in orthopedic surgery.
IPD
IPD en LUMC testen een innovatief handheld device voor het bestrijden van infecties in implantaten tijdens de FiH-studie.
SyCap Mechano
Avalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten.
Implant Preservation Device
Het project ontwikkelt een handheld inductie-apparaat om infecties bij metalen implantaten te bestrijden, wat de chirurgische behandeling vereenvoudigt en gezondheidszorgkosten verlaagt.
Precisie katheter ontwikkeling met Skeleton Backbone Technologie
Het project ontwikkelt innovatieve medische hulpmiddelen om patiëntgerichte zorg te verbeteren en productie in Nederland te versterken.